Latest News


Kolling researcher among hypertension thought leaders at international meeting .

Kolling Institute researcher and RNSH Senior Hospital Scientist Dr Anastasia Mihailidou says she was delighted to showcase the district’s work in blood pressure management on the world stage. Dr Mihailidou, who is head of the Kolling’s Cardiovascular and Hormonal Research Lab, presented at the recent International Society of Hypertension Scientific Meeting in Japan. Globally renowned academics and .....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Our research expertise recognised with multi-million dollar grants.

We would like to congratulate Professors Carol Pollock and Gemma Figtree who have received significant National Health and Medical Research Council Investigator Grants. Despite a tremendously competitive field, both clinician/researchers have been awarded $2 million to progress their world-leading research and improve long-term patient outcomes. The announcement highlights the experience and expert.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Outstanding career recognised with national accolade .

We would like to congratulate Kolling Institute researcher Professor Sarah Hilmer who has been elected a Fellow of the prestigious Australian Academy of Health and Medical Sciences. Professor Hilmer is part of a select group of researchers who have been admitted to the academy, which works to advance health and medical research across Australia. She has joined the highly-respected organisation in r.....
Read more

Category: Awards, Research Excellence

World Arthritis Day directs focus to the latest research and clinical trial opportunities .

Arthritis is the third most prevalent long-term health condition in Australia affecting more than 12 per cent of Australians. There is no cure for arthritis, with treatment options largely focused on alleviating pain, including pain relief medication, arthroscopy or joint replacement. Australia is at the forefront of clinical research and trials, which is helping the community better manage their a.....
Read more

Category: Musculoskeletal Research, Research Excellence

Researchers closer to better pain management strategies.

Researchers at the Kolling Institute have taken an important step towards the development of safer, non-addictive pain medications by increasing our understanding of spinal cord pain signalling. This valuable progress has been recognised internationally with publication in the Journal of Physiology, a leading scientific journal. The findings follow the latest figures indicating more than 20 per cen.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Kolling researcher recognised with prestigious international award.

We would like to congratulate Professor Chris Little who has received a highly coveted award for his outstanding commitment to orthopaedic research. Professor Little has been elected a Fellow of International Orthopaedic Research at a key international conference in Edinburgh Scotland. The award is only presented every three years, with around 20 people across the globe receiving the accolade. Fell.....
Read more

Category: Musculoskeletal Research, Presentations, Research Excellence

New robot driving innovation in joint surgery .

A $400,000 robot which may hold the key to significant improvements in hip and knee replacements is now operational at the Kolling Institute. Known as KOBRA or the Kolling Orthopaedic Biomechanics Robotic Arm, the new technology delivers an advanced testing facility, while greatly increasing research capabilities. It is the largest of its kind in Australia and one of just two SimVitro robots in the.....
Read more

Category: Musculoskeletal Research, Research Excellence, World-leading technology

Kolling researchers present at international congress.

Kolling Institute researchers have helped map out exciting future developments for the rehabilitation of hip and knee replacement patients. A team of researchers from Sydney Musculoskeletal Health – a partnership between the University of Sydney, Sydney Local Health District and Northern Sydney Local Health District - recently attended the International Society for Technology in Arthroplasty’s annu.....
Read more

Category: Musculoskeletal Research, Presentations, Research Excellence

Encouraging news for those with chronic kidney disease.

Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock. Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme. The listing aims to help those with the condition by.....
Read more

Category: Cardiovascular and Renal Research, New Treatment

New Academic Director shares vision for research success.

Ambitious leadership, functional wellbeing and a passion for collaboration An international healthcare destination celebrated for its collaborative spirits and dedication to human health and wellbeing. This is Professor Jim Elliott’s vision for how the collaboration between the Kolling Institute, the Faculty of Medicine and Health and the Northern Sydney Local Health District will evolve. Highly re.....
Read more

Category: Research Excellence